AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Neogen NEOG 2026Q1 Earnings Preview Upside Ahead on Revised Guidance
Generated by AI AgentAinvestweb
Monday, Oct 6, 2025 7:12 pm ET1min read
Forward-Looking Analysis
Analysts expect Neogen’s 2026Q1 earnings to show improvement, with Zacks Research forecasting an EPS of $0.11. This aligns with the company’s updated full-year 2025 guidance, which projected revenue between $905 million and $925 million. Neogen’s Q4 2025 results, while showing a net loss of $612.2 million due to non-cash goodwill impairment, included an adjusted net income of $11.3 million and EPS of $0.05—266.67% above the forecasted -$0.03. Adjusted EBITDA for Q4 was $40.6 million. With positive momentum in adjusted metrics and guidance for continued revenue growth, the path for 2026Q1 appears favorable.
Historical Performance Review
In Q4 2025, reported revenue of $225.46 million but incurred a net loss of $612.20 million, with an EPS of -$2.82. The loss was primarily driven by a non-cash goodwill impairment. Gross profit stood at $92.86 million. Despite the net loss, the company’s adjusted net income was $11.3 million, with an EPS of $0.05—well above the forecast.
Additional News
Neogen’s Q3 2025 results showed revenue of $221.0 million and a net loss of $11.0 million ($-0.05 EPS), though adjusted net income was $20.9 million ($0.10 EPS). The company updated its full-year 2025 revenue guidance to $905–$925 million. Zacks Research also projected Q4 2025 EPS at $0.09 and Q2 2026 EPS at $0.11. The Q4 earnings call transcript highlighted the strong performance relative to forecasts, with adjusted metrics beating expectations.
Summary & Outlook
Neogen’s financial performance in 2025 has been mixed, marked by a significant net loss due to non-cash impairments but strong adjusted earnings. The company’s revenue remains stable, with Q4 at $225.5 million and full-year guidance of $905–$925 million. Gross profit and adjusted EBITDA highlight operational strength. With a Q2 2026 EPS forecast of $0.11 and improved guidance, the outlook is cautiously optimistic. While earnings volatility remains a risk, Neogen’s strong revenue and adjusted metrics suggest a potentially bullish path ahead.
Analysts expect Neogen’s 2026Q1 earnings to show improvement, with Zacks Research forecasting an EPS of $0.11. This aligns with the company’s updated full-year 2025 guidance, which projected revenue between $905 million and $925 million. Neogen’s Q4 2025 results, while showing a net loss of $612.2 million due to non-cash goodwill impairment, included an adjusted net income of $11.3 million and EPS of $0.05—266.67% above the forecasted -$0.03. Adjusted EBITDA for Q4 was $40.6 million. With positive momentum in adjusted metrics and guidance for continued revenue growth, the path for 2026Q1 appears favorable.
Historical Performance Review
In Q4 2025, reported revenue of $225.46 million but incurred a net loss of $612.20 million, with an EPS of -$2.82. The loss was primarily driven by a non-cash goodwill impairment. Gross profit stood at $92.86 million. Despite the net loss, the company’s adjusted net income was $11.3 million, with an EPS of $0.05—well above the forecast.
Additional News
Neogen’s Q3 2025 results showed revenue of $221.0 million and a net loss of $11.0 million ($-0.05 EPS), though adjusted net income was $20.9 million ($0.10 EPS). The company updated its full-year 2025 revenue guidance to $905–$925 million. Zacks Research also projected Q4 2025 EPS at $0.09 and Q2 2026 EPS at $0.11. The Q4 earnings call transcript highlighted the strong performance relative to forecasts, with adjusted metrics beating expectations.
Summary & Outlook
Neogen’s financial performance in 2025 has been mixed, marked by a significant net loss due to non-cash impairments but strong adjusted earnings. The company’s revenue remains stable, with Q4 at $225.5 million and full-year guidance of $905–$925 million. Gross profit and adjusted EBITDA highlight operational strength. With a Q2 2026 EPS forecast of $0.11 and improved guidance, the outlook is cautiously optimistic. While earnings volatility remains a risk, Neogen’s strong revenue and adjusted metrics suggest a potentially bullish path ahead.
Ainvestweb
This internal account is for our software. It'll answer users' questions about subscription products, aiming to boost adoption and retention.
Latest Articles
Jabil's Q1 Beat: A Data Center-Driven Inflection Point or a Cyclical Mirage?
Dec.17 2025
Silver X's Stock Grant: A Turnaround Signal or a Warning for a Loss-Making Producer?
Dec.17 2025
Where 'Lynch' Persists: The Strategic Anatomy of Bank of America's Brand Rebrand
Dec.17 2025
Decoding the CEO Letter: A Historical Lens on Modern Investor Sentiment
Dec.17 2025
Amazon's OpenAI Bet: A Historical Parallel for Nvidia and Broadcom
Dec.17 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet